Data for validation analysis of the PROFFIT instrument to measure financial toxicity of cance
Background: Cancer may cause financial difficulties, but its impact in countries with public health ...
BACKGROUND: Cancer may cause financial difficulties, but its impact in countries with public health...
Purpose: Financial toxicity (FT) is a significant concern for patients with cancer. We reviewed pros...
To measure and explain financial toxicity (FT) of cancer in Italy, where a public healthcare system ...
Objectives To measure and explain financial toxicity (FT) of cancer in Italy, where a public healthc...
BACKGROUND The Patient Reported Outcome for Fighting FInancial Toxicity (PROFFIT) questionnaire w...
Introduction Financial toxicity (FT) is a well-recognised problem in oncology. US-based studies have...
Background:Financial toxicity in cancer patients has been initially reported in the United States an...
Introduction. Financial toxicity (FT) is a well-recognized problem in oncology. US-based studies hav...
Background This study aimed to develop a British version of the Patient Reported Outcomes for Fight...
Purpose: This paper illustrates a conceptual model for a new patient-reported outcome measure (PROM)...
Witte J, Mehlis K, Surmann B, et al. Methods for measuring financial toxicity after cancer diagnosis...
Financial toxicity as an individual consequence of a cancer diagnosis currently evolves to a clinica...
The term ‘financial toxicity’ is broadly used to describe the distress or hardship arising from the ...
Purpose: To identify a cut-off score for the COmprehensive Score for financial Toxicity (COST) to pr...
Background: Cancer may cause financial difficulties, but its impact in countries with public health ...
BACKGROUND: Cancer may cause financial difficulties, but its impact in countries with public health...
Purpose: Financial toxicity (FT) is a significant concern for patients with cancer. We reviewed pros...
To measure and explain financial toxicity (FT) of cancer in Italy, where a public healthcare system ...
Objectives To measure and explain financial toxicity (FT) of cancer in Italy, where a public healthc...
BACKGROUND The Patient Reported Outcome for Fighting FInancial Toxicity (PROFFIT) questionnaire w...
Introduction Financial toxicity (FT) is a well-recognised problem in oncology. US-based studies have...
Background:Financial toxicity in cancer patients has been initially reported in the United States an...
Introduction. Financial toxicity (FT) is a well-recognized problem in oncology. US-based studies hav...
Background This study aimed to develop a British version of the Patient Reported Outcomes for Fight...
Purpose: This paper illustrates a conceptual model for a new patient-reported outcome measure (PROM)...
Witte J, Mehlis K, Surmann B, et al. Methods for measuring financial toxicity after cancer diagnosis...
Financial toxicity as an individual consequence of a cancer diagnosis currently evolves to a clinica...
The term ‘financial toxicity’ is broadly used to describe the distress or hardship arising from the ...
Purpose: To identify a cut-off score for the COmprehensive Score for financial Toxicity (COST) to pr...
Background: Cancer may cause financial difficulties, but its impact in countries with public health ...
BACKGROUND: Cancer may cause financial difficulties, but its impact in countries with public health...
Purpose: Financial toxicity (FT) is a significant concern for patients with cancer. We reviewed pros...
DOI
Add to ORKG